Status:
COMPLETED
Effects of Aminophylline Bolus on TCI (Target Controlled Infusion) Concentrations at Burst Suppression Occurence
Lead Sponsor:
University of Padova
Conditions:
Anesthesia Brain Monitoring
Eligibility:
FEMALE
18-80 years
Brief Summary
Aminophylline is an intravenous drug commonly utilized for asthma. However, some preclinical studies and few case reports and case series have described its effects in lightining the anesthestic plan ...
Detailed Description
Aminophylline is an intravenous drug commonly utilized for asthma. However, some preclinical studies and few case reports and case series have described its utility in decrease the timing of return of...
Eligibility Criteria
Inclusion
- Undergo general anaesthesia with Targeted Controlled Infusion of Propofol (Eleveld model) and Remifentanil (Minto model)
- Burst Suppression accidental occurence during the induction phase of anesthesia.
Exclusion
- Neurological disease
- Psychiatric disease
- Obesity
- Hypothension during Burst Suppression episodes, other Burst suppression episodes during Anesthesia maintenance.
Key Trial Info
Start Date :
November 12 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 15 2024
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT06134037
Start Date
November 12 2023
End Date
March 15 2024
Last Update
April 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Treviso Regional Hospital
Treviso, TV, Italy, 31100